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Abstract Mutations in CCM1, CCM2, or CCM3 lead to
cerebral cavernous malformations, one of the most common
hereditary vascular diseases of the brain. Endothelial cells
within these lesions are the main disease compartments.
Here, we show that adenoviral CCM3 expression inhibits
endothelial cell migration, proliferation, and tube formation
while downregulation of endogenous CCM3 results in
increased formation of tube-like structures. Adenoviral
CCM3 expression does not induce apoptosis under normal
endothelial cell culture conditions but protects endothelial
cells from staurosporine-induced cell death. Tyrosine kinase
activity profiling suggests that CCM3 supports PDPK-1/
Akt-mediated endothelial cell quiescence and survival.
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Cerebral cavernous malformations (CCM) have a preva-
lence of about one in 200 individuals and can occur
sporadically or in an autosomal dominantly inherited
manner with 60% disease penetrance. Affected patients
present with chronic headaches, epilepsy, or hemorrhagic
stroke. Second hit somatic loss-of-function mutations in
CCM1 (KRIT1), CCM2 (OSM), or CCM3 (PDCD10) have
been identified within cavernous lesions [1].
The gene products of CCM1 and CCM2 were shown to
be important for endothelial cell–cell junction formation
and maintenance of endothelial barrier function [2, 3]. Most
recently, it could be demonstrated that CCM1 also inhibits
endothelial proliferation, apoptosis, migration, lumen for-
mation, and sprouting angiogenesis in primary human
endothelial cells [4]. In contrast, CCM3 remains without
precise endothelial cell function description. Originally,
CCM3 mRNA was found to be upregulated in an apoptotic
human myeloid cell line [5]. An apoptosis-inducing role
was suggested based on CCM3 overexpression experiments
in HeLa cells and siRNA-mediated inhibition of endoge-
nously increased CCM3 in serum-deprived human umbil-
ical vein endothelial cells (HUVECs) [6]. In contrast,
CCM3 was reported to promote cell proliferation in a
human prostate cancer cell line [7]. Endothelial cell-specific
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disruption of ccm3 in mice demonstrated that CCM3 is
essential for early embryonic vascular development and
acts through stabilization of VEGFR2 signaling [8].
The aim of this study was to characterize CCM3 function
in primary human endothelial cells. The isolation of highly
pure endothelial cells from CCM lesions has been hampered
by calcification of the resected lesions and the presence of
diverse cell types within CCM specimen including not only
cavernous but also normal neoangiogenic endothelial cells
[1]. Therefore, an adenoviral approach with almost 100%
transduction efficiency was used for overexpression of
human CCM3 in HUVECs (details are provided in
Supplementary Information (ESM 1)).
Adenoviral CCM3 overexpression did not result in a
significant proportion of cells with fragmented nuclear
morphology indicative of apoptosis as has been reported by
Chen et al. for CCM3-transfected HeLa cells [6] (Fig. 1a).
However, overexpression of CCM3 led to twofold reduc-
tion of cell proliferation, at least twofold reduced motility,
and a decreased ability to form complete capillary-like
structures on Matrigel. CCM3 depletion resulted in in-
creased tube formation when compared to siRNA control
and GFP-overexpressing cells (Fig. 1a–e, for details see
Supplementary Information (ESM 1)). This observation that
downregulation of endogenous CCM3 results in increased
formation of tube-like structures is in agreement with
previous ccm3 knockdown studies in zebrafish that
revealed excessive disorganized sprouting of subintestinal
vessels [9] identical to the vascular phenotype seen in ccm1
and ccm2 mutant zebrafish [10]. Given that CCM1, CCM2,
and CCM3 form a protein complex in vitro [11], our data
are also in line with CCM1 being a negative regulator of
sprouting angiogenesis [4].
Similarly, it was recently shown that CCM1 shifts the
balance from ERK-mediated proliferation to Akt-mediated
cell survival and endothelial quiescence [4]. Accordingly,
CCM3-transduced endothelial cells showed decreased
metabolic activity which we interpret to be a sign of
endothelial quiescence rather than cell death (Fig. 1f).
As observed for CCM1 [4], adenoviral CCM3 expression
per se did not induce apoptosis under normal endothelial cell
culture conditions (Fig. 1g). However, similar to CCM1,
CCM3 reduced the rate of staurosporine-induced cell death:
induction of apoptosis with 250 nmol/l staurosporine for 2 h
resulted in more than fourfold increased caspase 3/7
activities in GFP-overexpressing HUVECs. In contrast,
CCM3-overexpressing HUVECs showed only a less than
twofold increase in caspase 3/7 activities (Fig. 1g). These
data are in line with the observation by Chen and coworkers
that endogenous CCM3 expression is increased in HUVECs
30 min after induction of apoptosis by serum deprivation
prior to the increase of cleaved caspase three levels seen after
3 h [6]. However, our data demonstrate that upregulation of
CCM3 protects endothelial cells from staurosporine-induced
cell death rather than inducing it.
Tyrosine kinase activity profiling represents an unbiased
novel approach to dissect the mechanisms behind the
observed negative effects of CCM3 overexpression on
endothelial cell proliferation, migration, tube formation,
and apoptosis. Details on tyrosine kinase activity profiling
are provided in Supplementary Information (ESM 1).
HUVECs transduced with CCM3 demonstrated significant-
ly increased tyrosine 9-specific phosphorylation for 3-
phosphoinositide-dependent protein kinase 1 (PDPK-1,
data not shown). Elevated levels of PDPK-1 phosphorylat-
ed at its tyrosine-9 residue could be confirmed with
phosphospecific antibodies against PDPK-1 in HUVECs
overexpressing CCM3 (Fig. 1h). PDPK-1 had been shown
to be important for endothelial cell migration [12] and
formation of a circulatory system in embryonic mice [13]
and plays a central role in Akt activation upon growth
factor stimulation [14]. In accordance with the observation
that embryonic CCM3 knockout tissues showed decreased
Akt phosphorylation [8], CCM3 overexpression led to
increased phosphorylation of the potent inhibitor of
apoptosis Akt at threonine 308 and serine 473 (Fig. 1h)
[15]. Again, our data are in line with the fact that CCM1
expression increased the amount of phosphorylated Akt at
serine 473 [4]. Thus, CCM3 expression resulted in altered
phosphorylation patterns in endothelial cells including
activation of Akt and its upstream activator PDPK-1.
Fig. 1 Overexpression of CCM3 in HUVECs strongly impaired
endothelial cell proliferation, migration, tube formation, and apoptosis
and activated the PDPK-1/Akt survival pathway. a HUVECs over-
expressing GFP or CCM3 48 h after transduction and western blot
analysis with anti-CCM3 antibody revealing prominent overexpres-
sion of CCM3 (lane 3) and successful downregulation of endogenous
CCM3 (lane 4). b Cells overexpressing CCM3 (upper micrograph,
upper line, right wells) proliferated half as much as control cells
(upper micrograph, upper line, left and middle wells; lower line,
middle wells) and siCCM3-transfected cells (upper micrograph, lower
line, left wells). c The ability of endothelial cells to migrate was
strikingly reduced in cells overexpressing CCM3 (lane 2) when
compared to untreated (lane 1) and GFP-transduced cells (lane 3). d, e
CCM3-transduced cells showed decreased ability to form complete
capillary-like structures (d, lane 3; e, left panel). CCM3-depleted cells
showed a slight but significant increase in tube formation (d, lane 4; e,
right panel). f CCM3-transduced cells showed decreased metabolic
activity using WST-1 reagent assay compared to GFP-transduced cells
starting to get obvious 2 h after incubation. g Overexpression of
CCM3 had no effect on apoptosis under normal growth factor
conditions, but staurosporine-induced cell death was more than
twofold less in CCM3-overexpressing cells when compared to GFP-
overexpressing cells. h Western blot analyses of HUVEC lysates
overexpressing GFP (lane 1) or CCM3 (lane 2), respectively. Protein
expression was detected using anti-phospho-PDPK-1 (Tyr 9), anti-
phospho-Akt (Thr 308), and anti-phospho-Akt (Ser 473). Anti-Akt
staining served as loading control. Phosphorylation of PDPK-1 and
Akt was significantly elevated in CCM3-overexpressing cell lysates
(lane 2). *p<0.01
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Taken together, we show that CCM3 inhibits endothelial
cell migration, proliferation, and tube formation and supports
PDPK-1/Akt-mediated endothelial cell survival. Our data
suggest that CCM3 plays a crucial role in maintaining
endothelial integrity and protection from cell death.
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